Thomas Engelen

Thomas Engelen has a track record in creating value in Listed and in Private Equity backed investments in Life Sciences and Chemicals including financial and operational turn-around as part of MBO and MBI. Support to PE in Due Diligence in various European countries, Brazil and the USA on targets with Enterprise Value up to US$ 1 Billion. Current engagements include Chair at Innovatrain AG and Stan Chem International Ltd.